PerkinElmer Company Profile (NYSE:PKI)

About PerkinElmer (NYSE:PKI)

PerkinElmer logoPerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets. It provides analytical instrumentation for the industrial market, which includes the chemical, electronics, energy, lubricant, petrochemical and polymer industries. Its products include AAnalyst, Altus, Aquamatic, Avio, AxION, Clarus, DairyGuard, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, Cell carrier and cell::explorer. The Diagnostics segment is focused on reproductive health, emerging market diagnostics and applied genomics. Its products include AutoDELFIA, BACS-on-Beads, Bioo Scientific, BoBs, Datalytix, Dexela, Dexela CMOS FPDs, Evolution, ViaCord, and Zephyr.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NYSE:PKI
  • CUSIP: 71404610
  • Web:
  • Market Cap: $7.54 billion
  • Outstanding Shares: 110,214,000
Average Prices:
  • 50 Day Moving Avg: $66.08
  • 200 Day Moving Avg: $63.21
  • 52 Week Range: $45.35 - $70.16
  • Trailing P/E Ratio: 20.56
  • Foreward P/E Ratio: 21.19
  • P/E Growth: 2.33
Sales & Book Value:
  • Annual Revenue: $2.14 billion
  • Price / Sales: 3.53
  • Book Value: $22.13 per share
  • Price / Book: 3.09
  • Annual Dividend: $0.28
  • Dividend Yield: 0.4%
  • EBIDTA: $416.05 million
  • Net Margins: 16.80%
  • Return on Equity: 13.44%
  • Return on Assets: 6.85%
  • Debt-to-Equity Ratio: 0.45%
  • Current Ratio: 2.43%
  • Quick Ratio: 1.97%
  • Average Volume: 630,855 shs.
  • Beta: 0.74
  • Short Ratio: 4.31

Frequently Asked Questions for PerkinElmer (NYSE:PKI)

What is PerkinElmer's stock symbol?

PerkinElmer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PKI."

How often does PerkinElmer pay dividends? What is the dividend yield for PerkinElmer?

PerkinElmer declared a quarterly dividend on Monday, July 24th. Shareholders of record on Friday, October 20th will be given a dividend of $0.07 per share on Friday, November 10th. This represents a $0.28 annualized dividend and a yield of 0.41%. The ex-dividend date of this dividend is Thursday, October 19th. View PerkinElmer's Dividend History.

How were PerkinElmer's earnings last quarter?

PerkinElmer, Inc. (NYSE:PKI) released its earnings results on Thursday, August, 3rd. The company reported $0.67 EPS for the quarter, meeting analysts' consensus estimates of $0.67. The company had revenue of $547 million for the quarter, compared to analysts' expectations of $554.14 million. PerkinElmer had a net margin of 16.80% and a return on equity of 13.44%. PerkinElmer's quarterly revenue was up 2.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.67 earnings per share. View PerkinElmer's Earnings History.

When will PerkinElmer make its next earnings announcement?

PerkinElmer is scheduled to release their next quarterly earnings announcement on Monday, November, 6th 2017. View Earnings Estimates for PerkinElmer.

What guidance has PerkinElmer issued on next quarter's earnings?

PerkinElmer issued an update on its FY17 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of $2.84-2.92 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.85.

Where is PerkinElmer's stock going? Where will PerkinElmer's stock price be in 2017?

14 analysts have issued 1 year price targets for PerkinElmer's shares. Their predictions range from $48.00 to $81.00. On average, they anticipate PerkinElmer's share price to reach $67.42 in the next year. View Analyst Ratings for PerkinElmer.

What are analysts saying about PerkinElmer stock?

Here are some recent quotes from research analysts about PerkinElmer stock:

  • 1. According to Zacks Investment Research, "PerkinElmer holds ground on a strong global foothold, courtesy of its impending acquisition of Germany-based EUROIMMUN and takeover of India-based Tulip Diagnostics. The company continues to offer a global diagnostics portfolio focused on reproductive health, infectious disease screening and genomics offerings for oncology and other molecular tests. With an enhanced focus on product innovation and expansion into emerging markets, PerkinElmer has considerable potential upside. PerkinElmer delivered a solid first quarter, beating the Zacks Consensus Estimate on both the counts. The quarter witnessed solid organic revenue growth across all the business segments. Furthermore, a positive guidance instills our confidence on the stock. On the flipside, despite having a solid portfolio, unfavorable foreign exchange is a primary concern for PerkinElmer. Furthermore, PerkinElmer’s share price movement in the past one year has been unsatisfactory." (8/1/2017)
  • 2. Cantor Fitzgerald analysts commented, "Newborn screening in China continues to drive strong diagnostic growth, despite a slight decline in the Haoyuan nucleic acid testing. Diagnostic revenue in China was up more than 20% y/y in 1Q17. Despite a slight moderation in birth rates, uptake of the automated Genetic Screening Processor (GSP) has driven menu expansion. The company reports that 20-25% of the market is now screening for ~20 disorders, while the remaining 80% is screening for 2-4 disorders. India, the largest newborn screening opportunity with an estimated 26M annual births, continues to be relatively unpenetrated, but we do not anticipate a steep adoption ramp as the company experienced in China. Increase in reported revenue guidance leaves organic growth unchanged. The company raised its 2017 revenue guidance to $2.200-2.220B from $2.19-2.20B, implying 4-5% y/y reported revenue growth, compared with our prior estimate of $2.199B. Notably, the 4% organic revenue growth rate is unchanged, and the company expects a slightly lower FX headwind for 2017." (5/5/2017)

Who are some of PerkinElmer's key competitors?

Who are PerkinElmer's key executives?

PerkinElmer's management team includes the folowing people:

  • Robert F. Friel, Chairman of the Board, President, Chief Executive Officer
  • Frank Anders Wilson CPA, Chief Financial Officer, Senior Vice President
  • Deborah Butters, Chief Human Resource Officer, Senior Vice President
  • James L. Corbett, Executive Vice President and President - Discovery & Analytical Solutions
  • Joel S. Goldberg, Senior Vice President - Administration, General Counsel, Secretary
  • Prahlad R. Singh, Senior Vice President and President - Diagnostics
  • Daniel R. Tereau, Senior Vice President, Strategy and Business Development
  • Andrew Okun, Chief Accounting Officer, Vice President
  • Alexis P. Michas, Lead Independent Director
  • Peter Barrett Ph.D., Independent Director

Who owns PerkinElmer stock?

PerkinElmer's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.89%), Capital Research Global Investors (6.76%), Janus Henderson Group PLC (5.81%), BlackRock Inc. (5.39%), State Street Corp (3.50%) and Pictet Asset Management Ltd. (3.12%). Company insiders that own PerkinElmer stock include Alexis P Michas, Andrew Okun, Daniel R Tereau, Frank Anders Wilson, James Corbett, Joel S Goldberg, Kenton J Sicchitano, Patrick J Sullivan, Peter Barrett, Prahlad R Singh, Robert F Friel and Vicki L Sato. View Institutional Ownership Trends for PerkinElmer.

Who sold PerkinElmer stock? Who is selling PerkinElmer stock?

PerkinElmer's stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Shapiro Capital Management LLC, FIL Ltd, Schroder Investment Management Group, Sensato Investors LLC, Lord Abbett & CO. LLC, Systematic Financial Management LP and Westwood Holdings Group Inc.. Company insiders that have sold PerkinElmer stock in the last year include Alexis P Michas, Andrew Okun, Daniel R Tereau, Joel S Goldberg, Patrick J Sullivan, Peter Barrett, Prahlad R Singh, Robert F Friel and Vicki L Sato. View Insider Buying and Selling for PerkinElmer.

Who bought PerkinElmer stock? Who is buying PerkinElmer stock?

PerkinElmer's stock was bought by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Koch Industries Inc., Delta Lloyd Asset Management N.V., Vanguard Group Inc., Monarch Partners Asset Management LLC, BlackRock Inc., WINTON GROUP Ltd and Acadian Asset Management LLC. View Insider Buying and Selling for PerkinElmer.

How do I buy PerkinElmer stock?

Shares of PerkinElmer can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is PerkinElmer's stock price today?

One share of PerkinElmer stock can currently be purchased for approximately $68.45.

MarketBeat Community Rating for PerkinElmer (NYSE PKI)
Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  260 (Vote Outperform)
Underperform Votes:  285 (Vote Underperform)
Total Votes:  545
MarketBeat's community ratings are surveys of what our community members think about PerkinElmer and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for PerkinElmer (NYSE:PKI) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Sell Ratings, 8 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.14)
Consensus Price Target: $67.42 (1.51% downside)

Analysts' Ratings History for PerkinElmer (NYSE:PKI)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/26/2017Goldman Sachs Group, Inc. (The)Reiterated RatingNeutral -> Neutral$67.00LowView Rating Details
9/26/2017Citigroup Inc.Reiterated RatingBuy$80.00LowView Rating Details
9/1/2017Cowen and CompanyReiterated RatingHold$70.00LowView Rating Details
8/4/2017Piper Jaffray CompaniesReiterated RatingBuy$81.00MediumView Rating Details
7/16/2017Cantor FitzgeraldReiterated RatingHoldLowView Rating Details
7/13/2017Wells Fargo & CompanyInitiated CoverageMarket Perform -> Market Perform$72.00LowView Rating Details
7/10/2017Morgan StanleyReiterated RatingOverweight$73.00 -> $79.00LowView Rating Details
6/22/2017Evercore ISIReiterated RatingIn-Line$62.50 -> $68.00LowView Rating Details
6/20/2017Jefferies Group LLCReiterated RatingHold$58.00 -> $69.00MediumView Rating Details
5/6/2017Barclays PLCSet Price TargetSell$55.00LowView Rating Details
3/27/2017Janney Montgomery ScottUpgradeNeutral -> BuyMediumView Rating Details
2/5/2017BTIG ResearchReiterated RatingHoldN/AView Rating Details
2/3/2017Bank of America CorporationDowngradeNeutral -> Underperform$48.00N/AView Rating Details
1/18/2017Deutsche Bank AGReiterated RatingHold$55.00N/AView Rating Details
8/5/2016J P Morgan Chase & CoBoost Price TargetNeutral$52.00 -> $55.00N/AView Rating Details
8/5/2016MizuhoDowngradeBuy -> Neutral$56.00N/AView Rating Details
5/8/2016Robert W. BairdReiterated RatingBuyN/AView Rating Details
5/6/2016Stifel NicolausBoost Price TargetBuy$51.00 -> $59.00N/AView Rating Details
12/3/2015WedbushDowngradeOutperform -> Neutral$56.00N/AView Rating Details
(Data available from 9/26/2015 forward)


Earnings History for PerkinElmer (NYSE:PKI)
Earnings by Quarter for PerkinElmer (NYSE:PKI)
Earnings History by Quarter for PerkinElmer (NYSE PKI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/6/2017$0.72N/AView Earnings Details
8/3/2017Q2 2017$0.67$0.67$554.14 million$547.00 millionViewListenView Earnings Details
5/4/2017Q1 2017$0.54$0.55$506.81 million$514.12 millionViewListenView Earnings Details
11/7/2016Q3$0.66$0.68$572.03 million$548.00 millionViewListenView Earnings Details
5/5/2016Q116$0.51$0.56$532.55 million$538.70 millionViewN/AView Earnings Details
11/5/2015Q315$0.60$0.60$554.88 million$563.00 millionViewN/AView Earnings Details
7/30/2015Q2$0.59$0.60$555.66 million$564.00 millionViewListenView Earnings Details
4/30/2015Q115$0.46$0.50$537.27 million$526.90 millionViewN/AView Earnings Details
1/29/2015Q414$0.78$0.85$602.35 million$608.60 millionViewN/AView Earnings Details
10/30/2014Q3$0.57$0.67$550.40 million$542.05 millionViewListenView Earnings Details
8/7/2014Q2$0.59$0.59$572.26 million$556.20 millionViewListenView Earnings Details
4/24/2014Q114$0.44$0.46$531.31 million$531.90 millionViewListenView Earnings Details
1/30/2014Q413$0.70$0.73$588.95 million$594.00 millionViewListenView Earnings Details
10/30/2013Q313$0.48$0.49$523.84 million$524.30 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.48$0.51$532.95 million$543.30 millionViewListenView Earnings Details
4/25/2013Q1 2013$0.48$0.36$532.25 million$505.38 millionViewListenView Earnings Details
1/31/2013Q4 2012$0.65$0.65$577.94 million$577.00 millionViewListenView Earnings Details
10/25/2012$0.44$0.45ViewN/AView Earnings Details
8/2/2012$0.47$0.53ViewN/AView Earnings Details
4/26/2012$0.41$0.43ViewN/AView Earnings Details
2/2/2012$0.51$0.62ViewN/AView Earnings Details
11/3/2011$0.39$0.41ViewN/AView Earnings Details
8/4/2011$0.40$0.42ViewN/AView Earnings Details
5/5/2011$0.31$0.34ViewN/AView Earnings Details
2/3/2011$0.41$0.44ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for PerkinElmer (NYSE:PKI)
2017 EPS Consensus Estimate: $2.95
2018 EPS Consensus Estimate: $3.50
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.60$0.60$0.60
Q2 20171$0.67$0.67$0.67
Q3 20171$0.73$0.73$0.73
Q4 20171$0.95$0.95$0.95
Q1 20181$0.80$0.80$0.80
Q2 20181$0.85$0.85$0.85
Q3 20181$0.87$0.87$0.87
Q4 20181$0.98$0.98$0.98
(Data provided by Zacks Investment Research)


Current Dividend Information for PerkinElmer (NYSE:PKI)
Next Dividend:11/10/2017
Annual Dividend:$0.28
Dividend Yield:0.41%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:8.46% (Trailing 12 Months of Earnings)
9.69% (Based on This Year's Estimates)
8.67% (Based on Next Year's Estimates)
Dividend Payments by Quarter for PerkinElmer (NYSE:PKI)

Dividend History by Quarter for PerkinElmer (NYSE PKI)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for PerkinElmer (NYSE:PKI)
Insider Ownership Percentage: 2.20%
Institutional Ownership Percentage: 91.47%
Insider Trades by Quarter for PerkinElmer (NYSE:PKI)
Institutional Ownership by Quarter for PerkinElmer (NYSE:PKI)
Insider Trades by Quarter for PerkinElmer (NYSE:PKI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/19/2017Andrew OkunInsiderSell4,358$65.00$283,270.00View SEC Filing  
6/1/2017Peter BarrettDirectorSell10,000$63.22$632,200.00View SEC Filing  
5/15/2017Patrick J SullivanDirectorSell6,628$62.59$414,846.52View SEC Filing  
5/4/2017Robert F FrielInsiderSell25,100$60.00$1,506,000.00View SEC Filing  
4/27/2017Robert F FrielInsiderSell124,837$60.11$7,503,952.07View SEC Filing  
3/20/2017Andrew OkunInsiderSell3,000$57.27$171,810.00View SEC Filing  
3/13/2017Joel S GoldbergInsiderSell30,710$55.45$1,702,869.50View SEC Filing  
2/21/2017Alexis P. MichasDirectorSell8,308$55.60$461,924.80View SEC Filing  
2/15/2017Prahlad R SinghInsiderSell9,576$55.00$526,680.00View SEC Filing  
2/9/2017Daniel R TereauInsiderSell5,001$53.16$265,853.16View SEC Filing  
2/9/2017Vicki L SatoDirectorSell8,308$54.01$448,715.08View SEC Filing  
2/6/2017Daniel R TereauInsiderSell4,069$52.01$211,628.69View SEC Filing  
12/1/2016Alexis P. MichasDirectorSell15,000$51.00$765,000.00View SEC Filing  
9/22/2016Joel S GoldbergInsiderSell38,095$55.00$2,095,225.00View SEC Filing  
9/12/2016Daniel R TereauInsiderSell18,866$52.00$981,032.00View SEC Filing  
8/24/2016Kenton J SicchitanoDirectorSell15,189$54.87$833,420.43View SEC Filing  
8/17/2016Patrick J SullivanDirectorSell8,308$54.74$454,779.92View SEC Filing  
6/2/2016Alexis P MichasDirectorSell1,953$54.85$107,122.05View SEC Filing  
5/24/2016Robert F FrielCEOSell128,300$55.01$7,057,783.00View SEC Filing  
5/16/2016Robert F FrielCEOSell109,000$55.01$5,996,090.00View SEC Filing  
5/11/2016Robert F FrielCEOSell10,685$55.01$587,781.85View SEC Filing  
5/10/2016Vicki L SatoDirectorSell12,586$54.51$686,062.86View SEC Filing  
5/6/2016Robert F FrielCEOSell4,116$55.00$226,380.00View SEC Filing  
4/18/2016Daniel R TereauInsiderSell2,158$50.79$109,604.82View SEC Filing  
3/21/2016James CorbettInsiderSell1,723$48.74$83,979.02View SEC Filing  
2/24/2016Alexis P. MichasDirectorSell10,000$47.56$475,600.00View SEC Filing  
12/3/2015Kenton J SicchitanoDirectorSell10,216$51.05$521,526.80View SEC Filing  
11/3/2015Frank Anders WilsoninsiderSell16,380$52.69$863,062.20View SEC Filing  
10/23/2015Andrew OkunInsiderSell2,000$50.00$100,000.00View SEC Filing  
9/14/2015James CorbettInsiderSell3,000$47.59$142,770.00View SEC Filing  
9/3/2015Kenton J. SicchitanoDirectorSell12,586$47.88$602,617.68View SEC Filing  
6/5/2015Alexis P MichasDirectorSell20,000$52.25$1,045,000.00View SEC Filing  
6/3/2015Frank Anders WilsonInsiderSell16,380$52.60$861,588.00View SEC Filing  
3/27/2015Joel S GoldbergInsiderSell10,646$51.00$542,946.00View SEC Filing  
3/23/2015Andrew OkunInsiderSell2,000$50.09$100,180.00View SEC Filing  
3/20/2015James CorbettInsiderSell5,157$50.23$259,036.11View SEC Filing  
3/18/2015Joel S GoldbergInsiderSell9,000$49.00$441,000.00View SEC Filing  
3/6/2015Patrick J SullivanDirectorSell12,586$46.90$590,283.40View SEC Filing  
3/5/2015Alexis P MichasDirectorSell8,892$47.00$417,924.00View SEC Filing  
3/5/2015Joel S GoldbergInsiderSell9,000$47.00$423,000.00View SEC Filing  
2/10/2015Vicki L SatoDirectorSell24,000$45.55$1,093,200.00View SEC Filing  
2/9/2015Andrew OkunInsiderSell6,262$45.82$286,924.84View SEC Filing  
2/3/2015Nicholas A LopardoDirectorSell8,892$46.30$411,699.60View SEC Filing  
2/3/2015Robert F FrielCEOSell60,709$46.26$2,808,398.34View SEC Filing  
2/2/2015Robert F FrielCEOSell319,065$46.02$14,683,371.30View SEC Filing  
11/14/2014James C MullenDirectorSell8,892$43.73$388,847.16View SEC Filing  
11/13/2014Patrick J SullivanDirectorSell8,892$43.46$386,446.32View SEC Filing  
9/4/2014Kenton J SicchitanoDirectorSell8,892$44.98$399,962.16View SEC Filing  
7/2/2014Daniel R MarshakSVPSell12,000$48.00$576,000.00View SEC Filing  
6/26/2014Daniel R MarshakSVPSell10,000$46.60$466,000.00View SEC Filing  
6/19/2014James CorbettInsiderSell57,126$46.69$2,667,212.94View SEC Filing  
6/9/2014Maurice H TenneyInsiderSell5,504$47.26$260,119.04View SEC Filing  
6/9/2014Robert F FrielCEOSell124,858$46.70$5,830,868.60View SEC Filing  
6/5/2014Alexis P MichasDirectorSell9,146$46.30$423,459.80View SEC Filing  
6/2/2014Alexis P MichasDirectorSell5,854$45.00$263,430.00View SEC Filing  
6/2/2014Joel S GoldbergInsiderSell17,000$45.11$766,870.00View SEC Filing  
5/12/2014Alexis MichasDirectorSell5,000$44.40$222,000.00View SEC Filing  
4/29/2014Nicholas LopardoDirectorSell12,951$41.98$543,682.98View SEC Filing  
4/7/2014James CorbettInsiderSell22,027$45.11$993,637.97View SEC Filing  
3/12/2014Daniel MarshakSVPSell19,292$45.29$873,734.68View SEC Filing  
3/11/2014John LetcherSVPSell41,000$45.40$1,861,400.00View SEC Filing  
3/7/2014Andrew OkunCAOSell9,398$46.35$435,597.30View SEC Filing  
2/27/2014Alexis MichasDirectorSell5,000$45.25$226,250.00View SEC Filing  
2/14/2014Vicki SatoDirectorSell21,843$43.97$960,436.71View SEC Filing  
2/7/2014James MullenDirectorSell12,951$43.73$566,347.23View SEC Filing  
12/13/2013Maurice TenneyInsiderSell25,000$38.91$972,750.00View SEC Filing  
12/10/2013Daniel MarshakSVPSell12,183$39.59$482,324.97View SEC Filing  
11/14/2013Robert FrielCEOSell112,461$37.14$4,176,801.54View SEC Filing  
9/10/2013Robert F FrielCEOSell141,000$37.45$5,280,450.00View SEC Filing  
9/6/2013Andrew OkunCAOSell6,805$36.86$250,832.30View SEC Filing  
5/1/2013Alexis P MichasDirectorSell6,440$30.85$198,674.00View SEC Filing  
4/30/2013James C MullenDirectorSell6,440$30.31$195,196.40View SEC Filing  
4/11/2013Maurice H TenneyInsiderSell9,500$35.00$332,500.00View SEC Filing  
9/13/2012Robert F FrielCEOSell50,565$29.00$1,466,385.00View SEC Filing  
8/9/2012Kenton J SicchitanoDirectorSell9,454$27.93$264,050.22View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for PerkinElmer (NYSE:PKI)
Latest Headlines for PerkinElmer (NYSE:PKI)
DateHeadline logoPerkinElmer's (PKI) "Buy" Rating Reiterated at Citigroup Inc. - September 26 at 9:30 AM logo Brokerages Anticipate PerkinElmer, Inc. (PKI) Will Post Quarterly Sales of $552.30 Million - September 18 at 10:00 AM logoPerkinElmer (PKI) CFO Andy Wilson to Retire - September 17 at 6:50 AM logoPerkinElmer Announces Future Retirement of Andy Wilson, Chief Financial Officer - September 16 at 7:47 AM logo Analysts Anticipate PerkinElmer, Inc. (PKI) Will Announce Earnings of $0.73 Per Share - September 16 at 6:12 AM logoAnalyzing Edwards Lifesciences Corporation (EW) & PerkinElmer (PKI) - September 14 at 4:40 PM logoPerkinElmer and In-Depth Genomics Team Up for Whole Genome Sequencing Diagnostic Program for Rare Diseases - September 14 at 9:14 AM logoPerkinElmer, Inc. (PKI) Given Consensus Recommendation of "Hold" by Analysts - September 13 at 9:34 AM logoPerkinElmer, Inc. (PKI) Rating Reiterated by Cowen and Company - September 4 at 9:26 PM logoPerkinElmer, Inc. (United States) breached its 50 day moving average in a Bullish Manner : PKI-US : September 1, 2017 - September 2 at 7:30 AM logo$552.30 Million in Sales Expected for PerkinElmer, Inc. (PKI) This Quarter - August 30 at 8:34 AM logoPerkinElmer to Present at Morgan Stanley Global Healthcare Conference - August 29 at 6:41 AM logoContrasting PerkinElmer (PKI) and Edwards Lifesciences Corporation (EW) - August 29 at 6:22 AM logoPerkinElmer, Inc. Expected to Post FY2017 Earnings of $2.89 Per Share (PKI) - August 24 at 6:52 AM logoPerkinElmer, Inc. (PKI) Given Consensus Rating of "Hold" by Brokerages - August 19 at 9:02 AM logo Analysts Expect PerkinElmer, Inc. (PKI) Will Post Quarterly Sales of $550.95 Million - August 12 at 2:18 PM logoSee what the IHS Markit Score report has to say about Perkinelmer Inc. - August 10 at 6:52 AM logoPerkinElmer, Inc. (United States) – Value Analysis (NYSE:PKI) : August 8, 2017 - August 9 at 6:26 AM logoPerkinElmer, Inc. (PKI) Price Target Raised to $74.00 at Citigroup Inc. - August 7 at 7:30 PM logoPerkinElmer, Inc. (PKI) Issues Earnings Results - August 5 at 7:30 PM logoPerkinElmer, Inc. (PKI) Earns "Buy" Rating from Piper Jaffray Companies - August 5 at 4:20 PM logoPerkinElmer (PKI) Meets Q2 Earnings, Raises '17 Guidance - August 5 at 6:13 AM logoPerkinElmer (United States) (PKI) Q2 2017 Results - Earnings Call Transcript - August 4 at 7:03 AM logoPerkinElmer Launches Clinical Whole Genome Sequencing Services - August 4 at 7:03 AM logoInvestor Network: PerkinElmer, Inc. to Host Earnings Call - August 4 at 7:03 AM logoPerkinElmer Announces Financial Results for the Second Quarter of 2017 - August 4 at 7:03 AM logoPerkinElmer profit meets Street view, boosts 2017 forecast range - August 4 at 7:03 AM logoPerkinElmer meets 2Q profit forecasts - August 4 at 7:03 AM logoEdited Transcript of PKI earnings conference call or presentation 3-Aug-17 9:00pm GMT - August 4 at 7:03 AM logoPerkinElmer, Inc. (PKI) Updates FY17 Earnings Guidance - August 3 at 5:34 PM logoCan PerkinElmer (PKI) Spring a Surprise in Q2 Earnings? - August 1 at 4:27 PM logoPerkinElmer, Inc. (NYSE:PKI) Raised to "Buy" at Zacks Investment Research - August 1 at 3:22 PM logoPerkinElmer, Inc. (NYSE:PKI) Cut to Hold at Zacks Investment Research - July 31 at 12:44 PM logoPerkinElmer, Inc. (NYSE:PKI) Rating Lowered to Hold at BidaskClub - July 29 at 12:58 PM logoPerkinElmer, Inc. (United States) breached its 50 day moving average in a Bearish Manner : PKI-US : July 27, 2017 - July 28 at 6:48 AM logoPerkinElmer, Inc. (NYSE:PKI) PT Raised to $80.00 at Piper Jaffray Companies - July 25 at 11:38 AM logoPerkinElmer, Inc. (NYSE:PKI) Given Average Rating of "Hold" by Brokerages - July 25 at 9:32 AM logoPerkinElmer, Inc. Announces Quarterly Dividend of $0.07 (PKI) - July 24 at 5:48 PM logoZacks: Analysts Anticipate PerkinElmer, Inc. (PKI) Will Post Quarterly Sales of $552.68 Million - July 23 at 11:25 AM logo$0.67 Earnings Per Share Expected for PerkinElmer, Inc. (PKI) This Quarter - July 21 at 9:48 AM logoPerkinElmer, Inc. (NYSE:PKI) Rating Increased to Buy at Zacks Investment Research - July 19 at 1:56 PM logoCantor Fitzgerald Reiterates "Hold" Rating for PerkinElmer, Inc. (NYSE:PKI) - July 16 at 8:10 AM logoPerkinElmer to Hold Earnings Call on Thursday, August 3, 2017 - July 11 at 6:39 AM logoPerkinElmer, Inc. (NYSE:PKI) Stock Rating Reaffirmed by Morgan Stanley - July 10 at 10:20 PM logoPerkinElmer (PKI) Hits a 52-Week High on Multiple Positives - July 5 at 9:36 AM logoPerkinElmer, Inc. (PKI) Receives Consensus Recommendation of "Hold" from Brokerages - June 30 at 10:10 AM logoGroundbreaking Multi-Center Clinical Trial Confirms Low-Dose Aspirin Therapy Reduces Rate of Pre-Term Preeclampsia - June 28 at 4:35 PM logoZacks: Brokerages Anticipate PerkinElmer, Inc. (PKI) Will Post Quarterly Sales of $552.68 Million - June 28 at 9:50 AM logo$0.67 EPS Expected for PerkinElmer, Inc. (PKI) This Quarter - June 27 at 12:38 AM logoResearch Analysts Offer Predictions for PerkinElmer, Inc.'s FY2018 Earnings (PKI) - June 26 at 8:16 AM



PerkinElmer (PKI) Chart for Tuesday, September, 26, 2017

This page was last updated on 9/26/2017 by Staff